glp-1 news oct 21 2025 obesity drug Weight Loss Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap GLP-1 Weight-Loss Drug GLP-1 Analogues Strategic Business Report

Overview CJC-1295 is a modified synthetic analog of GHRH (Growth Hormone Releasing Hormone, or somatoliberin), the natural hypothalamic hormone responsible for stimulating growth hormone (GH) secretion from the anterior pituitary

Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease: a Danish population-based inception cohort with 10 years of follow-up

Every recipe takes 2 minutes or less to prep

doi: 10.1126/science.1063443 108 RidgwayN

Medications that employ gradual dose escalation over several weeks allow the gastrointestinal system to adapt progressively to the drug's effects

Cytochrome P450, family 1, subfamily a, polypeptide 2 (CYP1A2)